|

Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx

RECRUITINGSponsored by University Hospital, Strasbourg, France
Actively Recruiting
SponsorUniversity Hospital, Strasbourg, France
Started2025-07-11
Est. completion2026-07
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The diagnostic and pre-therapeutic assessment of squamous cell carcinomas requires a neck and chest CT scan and a neck and facial MRI, which is the most effective examination, to establish the TNM stage of the tumor. However, obtaining this complete assessment can delay treatment. Confirmation of the non-inferiority of 40keV dual-energy CT in BOLT compared to MRI would spare the patient an additional MRI examination, speed up the pre-treatment assessment, reduce the loss of opportunity due to delayed treatment, and free up MRI imaging slots, which are still insufficient in the region.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adult patient (≥18 years)
* presenting with oral or oropharyngeal squamous cell carcinoma proven by histopathological analysis of a biopsy
* having undergone a clinical examination with nasofibroscopy by an ENT surgeon specializing in cancer surgery
* a contrast-enhanced cervicofacial MRI
* and a contrast-enhanced cervicofacial DECT with BOLT maneuver.

Exclusion Criteria:

* A lesion other than oral or oropharyngeal squamous cell carcinoma
* A labial location
* A contraindication to performing one or both of the imaging examinations.

Conditions3

CancerOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.